MS Studies
Multiple Sclerosis New Zealand (MSNZ) is committed to supporting and promoting research that advances our understanding of MS and improves the lives of people living with the condition. This page lists current clinical trials and research studies in New Zealand that are seeking participants, as well as major research initiatives and resources for those interested in getting involved.
Current Clinical Trials and Studies in New Zealand
If you are interested in participating in MS research, the following studies and trials are currently seeking volunteers:
- Economic Burden of MS 2021
This study examines the total costs and benefits associated with MS, helping to inform public health policy and support services by understanding the broader impact of MS on individuals, families, and society. - O-Hand (Oratorio-Hand) Clinical Trial
Now recruiting adults with Primary Progressive MS (PPMS), this global clinical trial involves 1,000 participants and includes four sites in New Zealand: Waikato, Wellington, Christchurch, and Dunedin DHBs. The study aims to evaluate new treatment options for PPMS. - Clozapine and Risperidone Clinical Trial
This trial explores whether clozapine and risperidone-medications currently used for mental health conditions and known for their anti-inflammatory effects-can be effective treatments for MS - End of Life Choice Study
Seeking volunteers who are nearing the end of life and willing to share their views in an interview, this study aims to improve understanding of end-of-life care and decision-making in MS - Virtual Reality Exergaming Study
Investigating the use of VR-exergaming as a rehabilitation tool, this study explores whether virtual reality exercise can improve physical function and cognition in people with MS. - Vitamin D MS Prevention Trial (PrevANZ)
An Australia and New Zealand-based trial testing whether vitamin D supplementation can help prevent the onset of MS. - COMPANZ Project: Comparing Australia and New Zealand MS Populations
This research compares the long-term effects of disease modifying treatments (DMTs) in people with MS living in Australia and New Zealand. - Support for Male Carers
A study investigating the social support, carer burden, willingness to seek help, and gender-related attributes among males assisting those with MS.
How to Participate
If you are interested in taking part in any of these studies, please contact MSNZ or the research team listed with the study. Researchers are encouraged to submit participation opportunities for listing on this page. Once all required information is received and reviewed, details will be made available to the MS community.
Major MS Research Initiatives in New Zealand
- New Zealand Multiple Sclerosis Research Trust (NZMSRT):
The NZMSRT stimulates and supports MS research in New Zealand, including funding for clinical trials, epidemiological studies, and the development of a national MS registry. - MSBase:
A global research platform collecting anonymised data from tens of thousands of people with MS, with New Zealand clinicians and researchers actively contributing to and benefiting from this resource. - New Zealand Brain Research Institute (NZBRI):
Ongoing projects include the MS Incidence and Natural History Study, prevalence studies, genetic research (ANZgene Project), and MRI studies to better understand MS in New Zealand.
Information and Support
- Clinical Trials Information: Learn more about clinical trials and how they work on our Clinical Trials page.
- Grant Funding for Researchers: The NZMSRT offers grants and scholarships for clinicians, nurses, and scientists conducting MS research in New Zealand. See current funding opportunities.
- International Collaboration: MSNZ works with MS Research Australia, the International Progressive MS Alliance, and other global partners to accelerate progress toward better treatments and a cure.
Stay Informed
- Check back regularly for news and updates on new studies and participation opportunities.
- For the latest information on DMTs available for the treatment of MS in New Zealand, see our treatments page or consult your neurologist.